![Genome Characterization and Potential Risk Assessment of the Novel SARS-CoV-2 Variant Omicron (B.1.1.529) – ScienceOpen Genome Characterization and Potential Risk Assessment of the Novel SARS-CoV-2 Variant Omicron (B.1.1.529) – ScienceOpen](https://www.scienceopen.com/document_file/47777c21-a8ae-48b6-af6a-42b09dac5c80/ScienceOpen/image/zoonoses20210024_fig1.jpg)
Genome Characterization and Potential Risk Assessment of the Novel SARS-CoV-2 Variant Omicron (B.1.1.529) – ScienceOpen
![Mia Malan on Twitter: "[Thread] What is the potential impact of the new B. 1.1.529 #COVID19 variant? @rjlessells: 1. It's relatively simple to detect some B.1.1.529 cases, as it's possible to use PCR Mia Malan on Twitter: "[Thread] What is the potential impact of the new B. 1.1.529 #COVID19 variant? @rjlessells: 1. It's relatively simple to detect some B.1.1.529 cases, as it's possible to use PCR](https://pbs.twimg.com/media/FFCWwQDXEAErpCL.jpg)
Mia Malan on Twitter: "[Thread] What is the potential impact of the new B. 1.1.529 #COVID19 variant? @rjlessells: 1. It's relatively simple to detect some B.1.1.529 cases, as it's possible to use PCR
![Proposal to split B.1.1.529 to incorporate a newly characterised sibling lineage · Issue #361 · cov-lineages/pango-designation · GitHub Proposal to split B.1.1.529 to incorporate a newly characterised sibling lineage · Issue #361 · cov-lineages/pango-designation · GitHub](https://user-images.githubusercontent.com/686405/145027666-318a51b4-0053-4150-a2fc-783752442ae3.png)
Proposal to split B.1.1.529 to incorporate a newly characterised sibling lineage · Issue #361 · cov-lineages/pango-designation · GitHub
![Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study - The Lancet Infectious Diseases Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/6580e83f-8fd8-42dc-8e38-997b6c0cf7b8/gr1_lrg.jpg)
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study - The Lancet Infectious Diseases
![An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies | Nature Medicine An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-021-01678-y/MediaObjects/41591_2021_1678_Fig1_HTML.png)
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies | Nature Medicine
![Genome Characterization and Potential Risk Assessment of the Novel SARS-CoV-2 Variant Omicron (B.1.1.529) – ScienceOpen Genome Characterization and Potential Risk Assessment of the Novel SARS-CoV-2 Variant Omicron (B.1.1.529) – ScienceOpen](https://www.scienceopen.com/document_file/47777c21-a8ae-48b6-af6a-42b09dac5c80/ScienceOpen/large.png)
Genome Characterization and Potential Risk Assessment of the Novel SARS-CoV-2 Variant Omicron (B.1.1.529) – ScienceOpen
![SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households — Four U.S. Jurisdictions, November 2021–February 2022 | MMWR SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households — Four U.S. Jurisdictions, November 2021–February 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7109e1_TransmissionWithinHouseholds_IMAGE_25Feb22_1200x627.jpg?_=65787)
SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households — Four U.S. Jurisdictions, November 2021–February 2022 | MMWR
![What do we know about the new B.1.1.529 coronavirus variant and should we be worried? | Gavi, the Vaccine Alliance What do we know about the new B.1.1.529 coronavirus variant and should we be worried? | Gavi, the Vaccine Alliance](https://www.gavi.org/sites/default/files/vaccineswork/2021/Thumb/shutterstock_1924081337_h2.jpg)
What do we know about the new B.1.1.529 coronavirus variant and should we be worried? | Gavi, the Vaccine Alliance
Dr Emma Hodcroft on Twitter: "We now have B.1.1.529 sequences (designed at @nextstrain clade 21K) up in our Africa build. You can check them out below. These are from South Africa &
![Dr Emma Hodcroft on Twitter: "You can also see 21K (B.1.1.529) on the Shared Mutations page (& too big to screenshot!) to compare what Spike mutations we also see in other variants. Dr Emma Hodcroft on Twitter: "You can also see 21K (B.1.1.529) on the Shared Mutations page (& too big to screenshot!) to compare what Spike mutations we also see in other variants.](https://pbs.twimg.com/media/FFH2k-5XEAEd7YB.jpg)
Dr Emma Hodcroft on Twitter: "You can also see 21K (B.1.1.529) on the Shared Mutations page (& too big to screenshot!) to compare what Spike mutations we also see in other variants.
![Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein - Kumar - 2022 - Journal of Medical Virology - Wiley Online Library Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein - Kumar - 2022 - Journal of Medical Virology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d8f68879-5411-425c-815d-4619897e2e40/jmv27526-fig-0001-m.jpg)
Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein - Kumar - 2022 - Journal of Medical Virology - Wiley Online Library
![Vinod Scaria on Twitter: "What do we know about the B.1.1.529 variant of SARS-CoV-2 with a very large number of mutations An updated thread on emerging evidence. https://t.co/D8nzB6ssgg" / Twitter Vinod Scaria on Twitter: "What do we know about the B.1.1.529 variant of SARS-CoV-2 with a very large number of mutations An updated thread on emerging evidence. https://t.co/D8nzB6ssgg" / Twitter](https://pbs.twimg.com/media/FFDlYGhUYAEZrZi.png)
Vinod Scaria on Twitter: "What do we know about the B.1.1.529 variant of SARS-CoV-2 with a very large number of mutations An updated thread on emerging evidence. https://t.co/D8nzB6ssgg" / Twitter
![Emerging evidence on Omicron (B.1.1.529) SARS‐CoV‐2 variant - Sharma - 2022 - Journal of Medical Virology - Wiley Online Library Emerging evidence on Omicron (B.1.1.529) SARS‐CoV‐2 variant - Sharma - 2022 - Journal of Medical Virology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/395c5dce-9ec8-40e1-96bf-496403725325/jmv27626-fig-0005-m.jpg)
Emerging evidence on Omicron (B.1.1.529) SARS‐CoV‐2 variant - Sharma - 2022 - Journal of Medical Virology - Wiley Online Library
View of SARS-CoV-2 variant Omicron (B.1.1.529) is in a rising trend of mutations increasing the positive electric charge in crucial regions of the spike protein S | Acta Biochimica Polonica
![Transmission of Omicron (B.1.1.529) - SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19 - The Lancet Regional Health – Western Pacific Transmission of Omicron (B.1.1.529) - SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19 - The Lancet Regional Health – Western Pacific](https://www.thelancet.com/cms/attachment/0d39f1ef-9ee6-4bce-a428-16c4250c9e9f/gr1_lrg.jpg)
Transmission of Omicron (B.1.1.529) - SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19 - The Lancet Regional Health – Western Pacific
![Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles | PNAS Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles | PNAS](https://www.pnas.org/cms/10.1073/pnas.2200592119/asset/81c2d762-125b-4b5a-ae5a-dd9cb4bc5ff0/assets/images/large/pnas.2200592119fig01.jpg)
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles | PNAS
![Africa Centres for Disease Control and Prevention's Statement regarding the new SARS-COV-2 virus variant B.1.1.529 – Africa CDC Africa Centres for Disease Control and Prevention's Statement regarding the new SARS-COV-2 virus variant B.1.1.529 – Africa CDC](https://africacdc.org/wp-content/uploads/2021/11/coronavirus-africa-cdc.jpg)
Africa Centres for Disease Control and Prevention's Statement regarding the new SARS-COV-2 virus variant B.1.1.529 – Africa CDC
![Viruses | Free Full-Text | The Rise and Fall of SARS-CoV-2 Variants and Ongoing Diversification of Omicron Viruses | Free Full-Text | The Rise and Fall of SARS-CoV-2 Variants and Ongoing Diversification of Omicron](https://pub.mdpi-res.com/viruses/viruses-14-02009/article_deploy/html/images/viruses-14-02009-g001.png?1663239682)
Viruses | Free Full-Text | The Rise and Fall of SARS-CoV-2 Variants and Ongoing Diversification of Omicron
![Frontiers | Predictions of the SARS-CoV-2 Omicron Variant (B.1.1.529) Spike Protein Receptor-Binding Domain Structure and Neutralizing Antibody Interactions Frontiers | Predictions of the SARS-CoV-2 Omicron Variant (B.1.1.529) Spike Protein Receptor-Binding Domain Structure and Neutralizing Antibody Interactions](https://www.frontiersin.org/files/Articles/830202/fviro-02-830202-HTML/image_m/fviro-02-830202-g001.jpg)